After finishing at $0.41 in the prior trading day, Outlook Therapeutics Inc (NASDAQ: OTLK) closed at $0.40, down -3.91%. In other words, the price has decreased by -$0.0161 from its previous closing price. On the day, 1236228 shares were traded.
Ratios:
Our goal is to gain a better understanding of OTLK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.44.
CapitalOne Upgraded its Equal Weight to Overweight on December 27, 2023, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 20 ’23 when Dagnon Terry sold 520,000 shares for $1.14 per share. The transaction valued at 590,200 led to the insider holds 653,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 102.80M and an Enterprise Value of 128.99M. Its current Enterprise Value per Revenue stands at 23.71 whereas that against EBITDA is -2.48.
Stock Price History:
Over the past 52 weeks, OTLK has reached a high of $2.03, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.4075, while the 200-Day Moving Average is calculated to be 0.8010.
Shares Statistics:
The stock has traded on average 2.00M shares per day over the past 3-months and 1.05M shares per day over the last 10 days, according to various share statistics. A total of 260.26M shares are outstanding, with a floating share count of 147.51M. Insiders hold about 43.32% of the company’s shares, while institutions hold 11.49% stake in the company. Shares short for OTLK as of Feb 15, 2024 were 13.2M with a Short Ratio of 6.61, compared to 12.13M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.07% and a Short% of Float of 7.13%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.06, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.03 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.14 and -$0.25 for the fiscal current year, implying an average EPS of -$0.19. EPS for the following year is -$0.14, with 5 analysts recommending between -$0.05 and -$0.29.
